- Market Realist•43 minutes ago
Eli Lilly and Company (LLY) is a US pharmaceutical company headquartered in Indianapolis, Indiana. LLY deals with both human pharmaceuticals and animal health.
- Reuters•12 hours ago
The U.S. Food and Drug Administration (FDA) on Tuesday approved Roche Holding AG's multiple sclerosis (MS) drug Ocrevus, putting the potential blockbuster drug back on track after a delay caused by regulators' concerns over manufacturing issues. The infusible drug, known chemically as ocrelizumab, becomes the first U.S.-approved medicine for the primary progressive form of the neurological disease (PPMS). It is also approved to treat the most common form of the disease, known as relapsing-remitting multiple sclerosis (RRMS).
- Zacks•2 days ago
Merck & Co., Inc. (MRK) recently announced that its anti-PD-1 therapy, Keytruda, has received positive opinion from CHMP for the treatment of patients with relapsed or refractory classical hodgkin lymphoma (cHL).
MRK.BA : Summary for MERCK & CO INC CEDEAR (10 REP 1 - Yahoo Finance
Merck & Co., Inc. (MRK.BA)
Buenos Aires - Buenos Aires Delayed Price. Currency in ARS
Add to watchlist
|Day's Range||98.70 - 98.70|
|52 Week Range||97.55 - 105.00|
|PE Ratio (TTM)||70.00|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|